A U.S.-Canadian research collaboration led by Vanderbilt University Medical Center has identified common, age-associated changes in the blood as a risk factor for acute kidney injury, which occurs in more than 1 in 5 hospitalized adults worldwide.

Vanderbilt's Trent Rosenbloom, MD, MPH, on July 1 will begin a one-year term as chair of the Biomedical Informatics, Library and Data Sciences Review Committee of the National Library of Medicine.

Vanderbilt's Yash Choksi, MD, recently received the 2024 Research Investigator Early Career Faculty Award from the Southern Society for Clinical Investigation and Fabian Bock, MD, PhD, won the society's Research Scholar Award.

Vanderbilt University Medical Center is working with scientists around the U.S. to launch the first Phase III, multicenter, placebo-controlled trial to determine the effect of immunomodulation on Long COVID.

John H. Newman, MD, an acclaimed physician-scientist in Vanderbilt University Medical Center’s Division of Allergy, Pulmonary and Critical Care Medicine who made numerous contributions to the knowledge of pulmonary vascular disease, died on Tuesday, Feb. 20, after a several-month illness. He was 78.

An international genetic study using multiancestry biobanks has identified novel genetic locations associated with primary open-angle glaucoma, the most common type of glaucoma and the leading cause of irreversible blindness globally.

In a novel procedure, the Vanderbilt Heart & Vascular Institute (VHVI) successfully performed the first large-flange Innovalve transcatheter mitral valve replacement.